key: cord-0693928-fiqx5srf
authors: Safi‐Keykaleh, Meysam; Aliakbari, Fatemeh; Safarpour, Hamid; Safari, Mehdi; Tahernejad, Azadeh; Sheikhbardsiri, Hojjat; Sahebi, Ali
title: Prevalence of postpartum depression in women amid the COVID‐19 pandemic: A systematic review and meta‐analysis
date: 2022-02-28
journal: Int J Gynaecol Obstet
DOI: 10.1002/ijgo.14129
sha: c98332cf4ef135a8641c5a70c78678ea335f8719
doc_id: 693928
cord_uid: fiqx5srf

COVID‐19 outbreaks appear to be related to exacerbation of psychological problems such as depression and anxiety in high‐risk population such as pregnant women and the postpartum period due to stress and life‐threatening illnesses. The aim of this study was to evaluate the prevalence of postpartum depression (PPD) during COVID‐19. This study protocol is registered in PROSPERO with CRD42021278425 code. Data sources including Google Scholar, ISC, Magiran, Scopus, PubMed, Embase, and Web of Science and reference list of included articles were used to identify related studies. Observational studies that reported the prevalence of PPD in both Persian and English during COVID‐19 between January 20, 2020 and August 31, 2021 were included. Data were collected and analyzed with a random effects model for meta‐analysis. In this study, 671 initial articles were identified and after removing duplicates, 454 studies were screened and finally 24 studies entered the meta‐analysis stage. According to this study results PPD based on Edinburgh Postnatal Depression Scale (EPDS) ≥9, EPDS ≥10, EPDS ≥11, EPDS ≥12, EPDS ≥13, Postpartum Depression Screening Scale‐Short Form (PDSS‐SF) ≥17 and total prevalence was reported 12% (95% confidence interval [CI] = 0.07–17, I (2) = 97%), 27% (95% CI = 15–39, I (2) = 99%), 44% (95% CI = 40–49, I (2) = 0.0%), 27% (95% CI = 0.06–49, I (2) = 97.4%), 28% (95% CI = 18–39, I (2) = 98.5%), 37% (95% CI = 32–42), 28% (95% CI = 23–33, I (2) = 98.5%). The findings of this study showed that the prevalence of PPD in women is relatively high during COVID‐19. Therefore, considering the psychological consequences of the COVID‐19 pandemic and the importance of pregnancy and the postpartum period in terms of the emergence of mental disorders, especially depression, it seems necessary to perform interventions and physical and psychological support.

mental health outcomes, disproportionately affecting high-risk populations. 3, 4 Pregnancy and postpartum are challenging and are associated with disorders such as insomnia, relationship tension, and feelings of isolation, which have caused mood disorders in many women. On the other hand, environmental stressors such as natural disasters can exacerbate mood disorders during pregnancy. 5 Pregnant women experience high stress during epidemics. On the other hand, increased symptoms of depression and anxiety in pregnant women are associated with an increased risk of preterm delivery, postpartum depression (PPD) and behavioral problems in children. Therefore, pregnant women need social support during pregnancy because these measures reduce PPD. 6, 7 According to studies, COVID-19 has been associated with an increased risk of mental health problems in pregnant and postpartum women. 8 Postpartum depression disorder is the most common postpartum illness among women. 9 According to the DSM-5 definition, PPD occurs 4 weeks after delivery while others define it as commencing at any time in the first year after delivery. 10 Postpartum depression threatens not only the health of mothers but also the health of infants, and infants of depressed mothers may have developmental disorders, reduced cognitive function, as well as problems pertaining to social communication with their parents and peers. 11 Approximately 10%-16% of women in the postpartum period experience a period of major depression and many of them also suffer from anxiety disorders. 12 The results of a study in China showed that the prevalence of depression in pregnant women and postpartum women was 27.43%, and women who were worried about themselves or their baby developing COVID-19 were more prone to depression. 8 The results of other studies have shown that women who gave birth during COVID-19 had a higher rate of PPD than other women who gave birth during the non-COVID -19 period. 13 Studies have shown that several studies have been conducted to investigate the association between COVID-19 and PPD in mothers, but a comprehensive study was not found to examine the prevalence of PPD during COVID-19. Access to comprehensive and complete information about the rate of PPD during COVID-19

can be used as a reference for health system decisions and policies. Therefore, the research team decided to conduct a systematic review and meta-analysis study to assess the prevalence of PPD during COVID-19.

This systematic review and meta-analysis was done according to PRISMA guideline. 14 This study protocol was registered in PROSPERO with CRD42021278425 code. English from January 20, 2020 to August 31, 2021. Table 1 lists the search strategies in the database types.

In this study, inclusion criteria include observational studies that reported the prevalence of PPD in both Persian and English during COVID-19 between January 20, 2020 and August 31, 2021.

Exclusion criteria included mean and standard deviation of PPD, PPD reports among men, pregnant women, during epidemics other than COVID-19, as well as systematic review studies, interventional studies, case reports, and letters to the editor.

In this study, 671 studies were entered into the EndNote 7 software after the search results were completed, and after removing duplicates, titles, and abstracts, 454 studies were screened. In the next step, the two researchers independently studied 46 possible related studies in detail and selected 24 final studies.

The quality evaluation of the studies was done by two researchers independently and any disagreement between them was resolved through a third person. To evaluate cross-sectional studies from the checklist Appraisal tool for Cross-Sectional Studies (AXIS) Tool 15 was used. This tool has a score of 0-20. The Newcastle-Ottawa Scale (NOS) tool 16 was also used to evaluate other observational studies (cohort and case-control). This tool has eight items in cohort studies in three sections including Selection (four items), Comparability (one item) and Outcome (three items) and also in case-control studies eight items including selection (Selection (four items), Comparability (one item) and Exposure (three items). Also, to extract the required data, two researchers independently used a pre-prepared checklist including: first author, study site, sample size, tools, and the prevalence of PPD used.

In this study, the binomial distribution formula was used to calculate the standard error of prevalence in each study. Random effects model was used to estimate pooled measures and 95% confidence interval [CI] . The I 2 index was used to examine the heterogeneity between studies and heterogeneity less than 25%, 25%-50%, 50%-75% and more than 75% indicate no heterogeneity, moderate heterogeneity, high and very high. 17 The effect of heterogeneity on the prevalence of PPD was investigated by analyzing the subgroups based on the type of tools and also the cut-off points of the tools. Publication bias in the study was assessed using the Begg (95% CI = 0.06-49, I 2 = 97.4%, P = < 0.001). Seven studies were done based on EPDS ≥13 and PPD 28% (95% CI = 18-39, I 2 = 98.5%, P = < 0.001) was reported. One study was done based on PDSS-SF ≥17 and PPD 37% (95% CI = 32-42) was reported. Also, total prevalence of PPD in women during COVID-19, 28% (95% CI = 23-33, I 2 = 98.5%, P = < 0.001) (Figure 2 ). Index I 2 showed that heterogeneity between studies is very high (Figure 2 ). Based on the Begg test results (P = 0.084), the publication bias is not significant in the present study (Figure 3 ).

Based on the results of this review study, 24 articles were reviewed and meta-analyzed and the overall prevalence of PPD in the COVID-19 pandemic was reported to be 28%. Also, the results In this study, in addition to reporting the overall prevalence of PPD, a subgroup analysis was used to report the prevalence of PPD based on the type of instrument and cut-point. The results showed that according to EPDS ≥ 10 tool, the prevalence of PPD was 27% and according to EPDS ≥ 13, the prevalence of PPD was 28%. The results of another meta-analysis study that exam- 

The findings of this study showed that the prevalence of PPD in women was relatively high during COVID-19. Since PPD can lead 

The authors have no conflicts of interest.

The data that support the findings of this study are available from the corresponding author upon reasonable request.

The prevalence of generalized anxiety disorder among health care workers during the COVID-19 pandemic: a systematic review and meta-analysis. Front Psychiatry

A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations

Moms are not OK: COVID-19 and maternal mental health. Front Glob Womens Health

Triggering of postpartum depression and insomnia with cognitive impairment in Argentinian women during the pandemic COVID-19 social isolation in relation to reproductive and health factors

A mixed-methods pilot study of perinatal risk and resilience during COVID-19

Coronavirus disease 2019 (COVID-19) and pregnancy: combating isolation to improve outcomes

Elevated depression and anxiety symptoms among pregnant individuals during the COVID-19 pandemic

Prevalence of depressive symptoms among pregnant and postpartum women in China during the COVID-19 pandemic

A preventive intervention for pregnant women on public assistance at risk for postpartum depression

The association between delivery during the COVID-19 pandemic and immediate postpartum maternal cognitive function

Prenatal and postnatal anxiety and depression in mothers during the COVID-19 pandemic

The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial

Psychological impact of COVID-19 quarantine measures in northeastern Italy on mothers in the immediate postpartum period

Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement

Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS)

The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in metaanalyses

The prevalence of insomnia among health care workers amid the COVID-19 pandemic: an umbrella review of meta-analyses

A survey of postpartum depression and health care needs among Chinese postpartum women during the pandemic of COVID-19

Mental health status of pregnant and breastfeeding women during the COVID-19 pandemic-a multinational cross-sectional study

The risk for nonpsychotic postpartum mood and anxiety disorders during the COVID-19 pandemic

Psychosocial experiences of postnatal women during the COVID-19 pandemic. A UK-wide study of prevalence rates and risk factors for clinically relevant depression and anxiety

Anxiety, depression, and knowledge level in postpartum women during the COVID-19 pandemic

Psychological stress associated with the COVID-19 pandemic in postpartum women in Yokohama

Prevalence and factors associated with postpartum depression during the COVID-19 pandemic among women in Guangzhou, China: a cross-sectional study

Maternal mental health before and during the COVID-19 pandemic in the

Rio Grande birth cohort

Giving birth during the COVID-19 pandemic: the impact on birth satisfaction and postpartum depression

The effect of COVID-19 pandemic and social restrictions on depression rates and maternal attachment in immediate postpartum women: a preliminary study

Psychosocial factors associated with postpartum psychological distress during the COVID-19 pandemic: a cross-sectional study

Risk for probable postpartum depression among women during the COVID-19 pandemic

Effects of COVID-19 epidemic lockdown on postpartum depressive symptoms in a sample of Italian mothers

Prevalence of depression, anxiety, and perceived stress in postpartum Mexican women during the COVID-19 lockdown

Psychological status of postpartum women under the COVID-19 pandemic in Japan

Communication across maternal social networks during England's first national lockdown and its association with postnatal depressive symptoms

Impact of COVID-19 pandemic on postpartum depression among mothers of extreme and early preterm infants

Effect of COVID-19 on delivery plans and postnatal depression scores of pregnant women

The relationship between postpartum depression and social support during the COVID-19 pandemic: a cross-sectional study

Prevalence and factors associated with postpartum depression during the COVID-19 Pandemic among Women in Jeddah, Saudi Arabia: a crosssectional study

Effects of the COVID-19 pandemic on postpartum depression: a retrospective case-control study on a significant sample of mothers in northern Italy

Mental health of pregnant and postpartum women during the coronavirus disease 2019 pandemic: a systematic review and meta-analysis

Mental health effect of COVID-19 pandemic among women who are pregnant and/or lactating: a systematic review and meta-analysis

Prevalence and risk factors of postpartum depression in the Middle East: a systematic review and meta-analysis

Rate and predictors of postpartum depression in a 22-year follow-up of a cohort of earthquake survivors in Armenia

The prevalence of anxiety and depression among healthcare workers during the COVID-19 pandemic: an umbrella review of meta-analyses

Consequences of maternal postpartum depression: a systematic review of maternal and infant outcomes

The COVID-19 outbreak increases maternal stress during pregnancy, but not the risk for postpartum depression

Postpartum depression and risk factors among Vietnamese women

Postpartum depression risk factors: a narrative review

Prevalence of postpartum depression in women amid the COVID-19 pandemic: A systematic review and meta-analysis